Invasive Brain-Computer Interface Medical Device Approved in China

China approves first invasive brain-computer interface device

China has officially approved the registration of an innovative product from Neuracle Medical. This marks a historic moment as the world’s first invasive brain-computer interface device enters clinical application.

This approval by the National Medical Products Administration (NMPA) signals a major breakthrough in the field of neurotechnology. The system is designed to restore hand function for patients with severe spinal cord injuries.

What is the Brain-Computer Interface Device?

The product consists of an implant, electrode kits, a signal transceiver, and a pneumatic glove. It is a sophisticated brain-computer interface device that bridges the gap between the brain and physical movement. Unlike non-invasive options, this system uses epidural minimally invasive implantation technology. It features wireless power supply and communication, ensuring a safer experience for patients.

Benefits of the Brain-Computer Interface Device

The device is specifically designed for patients aged 18 to 60. Candidates must suffer from quadriplegia caused by C2-C6 cervical spinal cord injuries. According to the NMPA , patients must be in a stable condition for at least six months before using the device. Clinical trials have demonstrated that this brain-computer interface device significantly improves hand grasping abilities. This restoration of motor function greatly enhances the quality of life for patients who have lost hope of movement.

Innovation and Clinical Results

The device uses epidural minimally invasive implantation technology. It also features wireless power supply and communication. Clinical trials showed significant improvement in hand grasping ability. This greatly improves the quality of life for patients.

Regulatory Support and Future Impact

In recent years, China has prioritized the development of high-end medical equipment. Brain-computer interfaces are identified as a key future industry. The NMPA provided “pre-review services” to accelerate this product’s launch. This efficient regulatory process highlights China’s growing capability in medical innovation.

Future Outlook

Moving forward, post-market supervision will be strictly enforced to ensure patient safety. This milestone solidifies China’s position as a leader in the global medical device market. You can find more insights on such innovations in our Health & Medical Insights category.

[Editor in charge: Wang Yuqi]